Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
¨The CRO knows the results are groundbreaking. But the CRO can't release the results because deadbeat Leo won't pay.
So.... ¨
Why not pay the CRO with shares much like they did with Ascroft and Sullivan? Heck, P is worth at least 10B, maybe 15B. The pay back to the CRO would be astronomical. Ah, never mind.
Call Leo, or one of the phase 2b trial sites near you near you, and ask about enrolling in the next prurisol trial.
Good luck, and let the board know of any feed back(if you don´t mind)..
¨They know much more than the retail investors know. JMO!!!¨
Good point. What does the new funding source know that Aspire does not, or was not told.
¨There are two people I know who work very hard there. However, they could be both out today but it is a working office and what you say is wrong.¨
Have ever been there? One knows they (the two hardly working people) are there when the dunce cap and tin foil hat sit upon the hat rack.
You´re right. There is some furniture, but it says nothing either.
PMTX,
I agree, lawyers are, for the most part, unscrupulous.
Kavanaugh may come after you for your sully remark to his(the) ¨profession¨.
¨Q3 Potential Milestones
1. B-OM - Breakthrough Therapy Designation
2. Prurisol - Top-line Data (Phase 2b)
3. Licensing Agreement (double-digits millions upfront payment)¨
Sorry sox, but until their words ever ring true, your 3 noted ponts have become a broken record, much like George´s(nice guy I´m sure) carnival barking.
IT´S(some sort of verifiable result for any product) BEEN WAY TOO LONG.
I consider myself a patient man. This company is wearing out my threshold. They have walked all over shareholders to this point. Anyone who argues otherwise must be a student of the Perkins School.
I´ve contacted the Boston Business Journal(Seiffert,Stendahl) who have two or three stories on Cellceutix(now Innovation Pharmaceuticals), multiple times within the past year. Appears they have no interest in ipix.
Q1: "Who says they still haven’t paid?"
A1: Have you read the 10K?
Q2: Let’s speculate. Ever think that maybe The CRO made promises in the beginning about the amount of patients they’d get if IPIX set up their study in such and such location. They failed to get those promised patients which force IPIX to open more sites to play catch up. Whose at fault?
A2: I measure, rather than "speculate". My investment in this disaster was prompted by managements unequivocal bolster, which I trusted.
Q3: They failed to get those promised patients which force IPIX to open more sites to play catch up. Whose at fault? Why should IPIX pay for the CRO’s mistake of over estimating the amount of patients they’d get and for setting up a trial where another one was already taking place.
A3: Very good question. Who over-estimated, and why, I might add?
We(ipix) are in hurricane Florence territory, regarding investment returns.
IDK
¨What I don't get is why those share prices were used and whether they would be used no matter when the shares were returned, as the Form 4s suggest.¨
Best I can surmise is it is the company way of ¨robbing Peter(shareholders) to pay Paul(management)¨.
I suspect we´ll see similar filings from others in management b4 we see btd, p results, deal announcement(s), etc.
It´s my understanding that they converted a large swath of the office to a commercial kitchen and will offer a course entitled ¨Exquisite Cook Booking¨(for only a couple grand), for which successful participants will be given a ¨certificate of completion¨.
George,
You state: ¨Not if when!!!¨, in response to Basil22´s post #244964 , which reads, ¨I would do cartwheels if it hits $30.¨
Are you, or Basil22, referencing share price, or market cap, regarding the $30 figure? Do you include potential reverse splits in your responses, as far as ¨hitting $30?¨, (or tripling by end of Feb(whatever year that was:)).
p.s- Please define what¨Not if when!!!¨ means. A grammaitcally challenged statement for sure, like I´ve never seen.
TIAB,
You state:
¨markets do poorly- but IPIX can always do worse¨
That´s grammatically inaccurate in my view(sorry to nit pick).
I would amend your statement to read as follows:
markets do poorly- but IPIX always does worse.
Ipix is, eveidently, on the front lines of something, just not sure what(yet).
Over and out.
Just google the address.
¨However management says Purchaser is a "multi-family office of investors in healthcare and life sciences." I believe them.¨
The office with the multi-family investors is probablly one floor up in suite 247c.
¨PS: Leo is not a HNWI, but he wants to be, he's been working towards it a long time. Not a spring chicken, the only path for Leo to honeywee-ness is if IPIX succeeds.¨
Apparentley, a big if at that.
Thanks for the post, as well as your post of your 9/29/17, great contribution. Appears to me that you, and a few others(George, et.al) are trying to steer sentiment(for personal gain, in my view, based upon historical outcome).
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135024214
¨The effect of this pr is like if you were expecting a car for your 16th birthday but instead you get a stingray bike with a banana seat. We ned that car.¨
We got a rusted & crushed matchbox car that le found in a parking lot.
This thing will be pounding its way up real soon´
Funny
We have seen words like this before??
¨Our business is managed by our officers. Our Chief Operating Officer, **, began devoting full-time efforts to the Company on .... . Our Corporate Secretary, **, devote part time efforts to the Company’s activities. There are no additional employees. The Company relies on a team of highly experienced scientific, medical, and regulatory consultants to conduct its drug development activities.¨
¨I think you are very wrong. I believe Aspire still holds a large amount of stock. Aruda has no agreement and longs at this point would not dump stock. Too close to the possibility of something good happening.
I believe Aruda was the seller.¨
I think they´ve both been selling. Aspire was given free shares, as well as shares for as little as 25 cents, which they´ve likely cast off.
On the the other hand, Aruda was GIVEN millions of free shares, years ago, and stands likely to do well whenever, or if(hopeful) he ever decides to cut ties. He can´t lose- worst case break even- if he´s that stupid, and holds if it goes to zero.
¨Leo & IPIX Management bring home the bacon and watch this company sore to new heights!!!.... .imho,tryz ¨
Shareholders are sore enough and have a sour opinion of ipix management´s inability to meet their stated milestones.
I hope we do change coarse and soar upward to new heights.
¨I’m sensing a volume surge and move to ..29/.32 by 2:30 today. Anyone else getting that feeling? Kind of a tingling in the leg, like a Chris Mathews upon hearing Obama speak. Hmm.¨
The above statement is supposed to be encouraging for (new) investors?
I suspect a homeless person awakes each dawn with the same sort of hope, or feeling, on the way to the traffic lights or exit ramp.
¨per the agreement the share price would be allowed to count on the next trading day. So Monday would count and any news at this point squeezes and will reach .50 in a second. I don’t want these milestone shares if we are going to close a deal in the next 30 days.
Let’s stay at 163¨
That´s not how I read it but hope you´re right. Could you explain your interpretation of it?
Thx
ps- per the 6/29/18 prospectus filing,
https://research.ameritrade.com/grid/wwws/stocks/secfilings/filing.asp?data=B64ENCeyJEb2N1bWVudEtleSI6IjEzNy0wMDAxNDc3OTMyMTgwMDMyNTItN1MwVjNBTzZWMjcwQzBTUDUzNkVWTDJTODAiLCJGT1JNQVQiOiJIVE0iLCJGT1JNX1RZUEUiOiI0MjRCNSIsIkRvY3VtZW50RGF0ZV9mIjoiNi8yOC8yMDE4In0%3d&c_name=invest_VENDOR,
Appears, as of the execution of the 6/29/18 filing noted above, that the outstanding shares out there are 176.2 million shares, not 163M as you note. Just for the record.
Back to the above quote,¨¨per the agreement the share price would be allowed to count on the next trading day. So Monday would count and any news at this point squeezes and will reach .50 in a second. I don’t want these milestone shares if we are going to close a deal in the next 30 days. That´s not how I read it but hope you´re right. Could you explain your interpretation of it?
Thx
¨B BTD and deal timing are unknown, and nothing magical about Sep 30. That was an estimate by the company from end of June, and some things have taken longer than expected,....¨
Talk about an understatement. What have the done expeditiously recently, if ever?
¨Let’s see if Leo makes a last stand.¨
That means he would have to get off his a**. Don´t hold your breath.
Agree,
I swooned in on over 400,000 shares in one felled swoop.
BooDog,
You state: ¨Think I'm about ready to see $IPIX go mainstream.¨.
Hope you´re right.
I think I saw a Budget rental truck in the Beverly parking lot with a sign saying Help Wanted, MA minimum wage gauranteed, strong backs required for quick move.
IDK
¨Not that hard to find. The definition's right there on page 2.¨
You are correct. Not hard to understand.
TY.
kfc
LR,
You state:
¨Not that hard to find. The definition's right there on page 2¨
IDK, aint that smart myself. GL to the rest of you.
Thanks for all your posts!
Pepperchino,
¨or (iv) upon a change of control of the Company, as defined in the Company's 2016 Equity Incentive Plan.¨
Interesting. Does KM´s(Krishna Menon) termination allow the engagement of this clause(#iv)?
Astute question, thanks for posting.
kfc
TIAB,
1. ¨The company posts pretty careful comparative data for B OM that appears to justify BTD, and yet share price is goin' nowhere.¨
R1. I agree, nor can make sense of it, other than just taking longer likely due to staffing. IDK.
2. ¨IPIX on such shaky ground cannot get traction¨
R2. IDK. Certain Ihub posters manipulation?
3. Must wait for real actual news and we don't know when that might be near. For instance: no word on when BTD expected, or not.
R3. I guess, IDK.
4. NO word on HQ even
R4. Correct. I believe LR(sorry if it wasn´t you, think it was) may have addressed this via his/her intreptation of sec documents?
That´s all folks!
IDK
seekthelight,
You are correct, ¨These options have not even vested yet; so how could they exercise them.(?)¨
Certain execs have common stock awards(free shares) from previous years. Reference AB 2017 common stock award of 1,066,667 shares of which, per note 1, ¨Represents restricted stock which vests in two equal annual installments beginning on September 1, 2018 or upon the occurrence of certain events.
Without going into prior years, based on the referenced 2017 award, 533,333 shares can be sold as of 25 days ago.
https://www.sec.gov/Archives/edgar/data/1355250/000112329217001401/xslF345X03/edgar.xml
zandant,
Thx, glad you read as intended. What would be a very positive sign is if the company higher ups (AB, JH, LE, etc..) bought on the open market now which would be~28% less per share than the exercise price of .398.
¨Any thoughts on the options exercised by H and B in this morning's filings?¨
Appears to me that neither one exercised their options, but your dd is better than mine.
As the exercise price of .398 was barely exceeded into the 40 cent area for lmited periods of time during September (7th, 8th, and 12th) and staued above .398 on one day(the 11th on a low toral volume day of ~67k shares traded), they would have to be dumber than rocks to exercise the options- ah, your probablly right.
That explains things...
IDK
DaubersUP,
If you wouldn´t mind, why do you think that way?
Hope you are right, and that it is a key hire, but I see not the tell tale signs which you do.
I find your post curious, is all.
Thx
¨"with acceleration of vesting upon certain events."
Here we go again.¨
Ahh, good one Beavis. Urhh, wait a minute Beavis-what does that mean and where did you find that-ha-ha, ha-ha.
Butt Head
ps-this post is meant as humor only, understand you may not have ever seen Beavis and Butt Head, twas quite popular during my years at Yale.
You may be right, and I hope you are, but the company pr´s have proven, over the past several years, to be ineffectual, as was todays.
IDK
¨Maybe Dr M is ill and can’t resign.¨
Maybe, though well enough to serve on the Board of Directors?
Your logic, please.
Maybe someone at HQ read this: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143647327, which states:
¨
"Leo Ehrlich, the Company’s Chief Executive and Financial Officer, and Dr. Krishna Menon, Chief Scientific Officer, presently have no employment agreement with the Company."
Why not? The ineffective Board isn't like to chase either of them off if the spirit moves them but if the statement that followed that one in the 10-K is true ("The loss of a member of the senior management team could have an adverse impact on our business.") one wouldn't want them to toddle off on their own without notice, which they can now do. Unlikely? Maybe.
"The Compensation Committee held one meeting in fiscal 2018." I suspect that was about AB's bonus (or KM's pay cut...don't remember the exact timing of that).
In the last (and only) Annual Shareholder Meeting two legally required votes were taken:
"The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers as described in the proxy statement was approved by the stockholders".
"At the Annual Meeting, the Company's Board of Directors recommended, and approximately 52% of the stockholders voting on the proposal (not including 79,381 abstentions) chose, to have the Company hold future advisory votes on executive compensation on an annual basis. In light of the foregoing, the Company intends to hold future advisory votes on executive compensation on an annual basis."
It's just "on an advisory basis" and that vote is almost 3 years old so maybe people have forgotten about it, but the rule requiring the vote was instituted primarily to 1)keep investors aware of the level of Officer's compensation and 2)to allow them to express their feelings about it publicly. As far as I know the Company hasn't complied.
In the discussion of potential partnerships the focus has properly been on the drugs, but if there should come a day when the Company itself is the target a Partner would want these things...contracts and salaries...settled and in writing even if shareholders don't see that as a priority.
ps. KM signed the 10-K Certifications as President of Research and Director. Shouldn't he appear here?
ITEM 11. EXECUTIVE COMPENSATION
SUMMARY COMPENSATION TABLE
I know he's a part timer but can he be an Officer for the purpose of the Certification and not an Executive for the purpose of Compensation Table?
pps. This is more important and maybe more confusing than any of the above:
I looked at the Company's Entity file at NVSOS.gov and it shows two things of interest.
One is that AB is the President and based on the Certification requirements would appear to be the appropriate second signer versus KM who isn't listed as an Officer (Director only) and whom the Company calls its "President of Research". The Certification requirements call for the signatures of the two people who have the duties of CEO and CFO.
But that's not nearly as confusing as why, at what I would expect to be a time for the Company to be exercising an abundance of caution, they have allowed the Company to slip into Default status with the State. Their Annual Report (a very simple filing) was due on 8/31 and it wasn't made. I don't know why. The State provides a notification (actually more than one) to the Company and its Registered Agent in advance of the due date.
It's NOT a big deal (unless one of the Officers/Directors to be listed on the Annual List is a problem for some reason) so I would expect the Company to address it immediately.
https://www.nvsos.gov/SOSEntitySearch/FeeDetails.aspx?ctok=P141b32cuDeU7D3TKsnZcg%253d%253d ¨
IDK
They have navigated the process flawlessly under tremendous leadership of the founders.
They have (3) phase 3 studies, the 1200 patient study you noted the 600 patient study entitled ¨Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease¨, and Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Evidently the same drug in all 3 studies.
https://clinicaltrials.gov/ct2/show/study/NCT03440385?term=Ozanimod&rank=5&show_locs=Y#locn
https://clinicaltrials.gov/ct2/show/NCT03440372?term=Ozanimod&draw=3&rank=6
In the car seats, management is kicking themselves for not putting a couch in the lobby.
In response to: ¨you may be right....any idea where they will find $ after Aspire?¨